February 26, 2025

Enveda adds millions to Series C haul

Boulder-based Enveda Biosciences, which uses machine learning to discover naturally occurring drug compounds, recently added $20 million to its Series C round, bringing the fundraising effort’s total to $150 million. 

Related Posts

A Maryland native, Lucas has worked at news agencies from Wyoming to South Carolina before putting roots down in Colorado.
Sign up for BizWest Daily Alerts
Closing in 8 seconds...